Hubei Hongyuan Pharmaceutical Technology Co (SZSE:301246) Accounts Payable & Accrued Expense : ¥687 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Hubei Hongyuan Pharmaceutical Technology Co Accounts Payable & Accrued Expense?

Hubei Hongyuan Pharmaceutical Technology Co's quarterly accounts payable & accrued expense increased from Sep. 2023 (¥580 Mil) to Dec. 2023 (¥704 Mil) but then declined from Dec. 2023 (¥704 Mil) to Mar. 2024 (¥687 Mil).

Hubei Hongyuan Pharmaceutical Technology Co's annual accounts payable & accrued expense increased from Dec. 2021 (¥450 Mil) to Dec. 2022 (¥1,048 Mil) but then declined from Dec. 2022 (¥1,048 Mil) to Dec. 2023 (¥704 Mil).

Hubei Hongyuan Pharmaceutical Technology Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Hubei Hongyuan Pharmaceutical Technology Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hubei Hongyuan Pharmaceutical Technology Co Accounts Payable & Accrued Expense Chart

Hubei Hongyuan Pharmaceutical Technology Co Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

308.17

243.72

450.37

1,047.93

704.49

Hubei Hongyuan Pharmaceutical Technology Co Quarterly Data
	Jun15	Dec15	Jun16	Dec18	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															899.37	708.04	579.87	704.49	687.45

Hubei Hongyuan Pharmaceutical Technology Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Hubei Hongyuan Pharmaceutical Technology Co (SZSE:301246) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hubei Hongyuan Pharmaceutical Technology Co Ltd (SZSE:301246) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

N/A

Address

No. 8, Hongyuan Road, Economic Development Zone, Luotian County, Hubei Province, Fengshan Town, CHN, 438600

Website

http://www.hbhypharm.com

Hubei Hongyuan Pharmaceutical Technology Co Ltd is engaged in the research and development, production and sales of organic chemical raw materials, pharmaceutical intermediates, raw materials and pharmaceutical preparations.

Hubei Hongyuan Pharmaceutical Technology Co (SZSE:301246) Headlines

No Headlines